FilingReader Intelligence
Beijing BaiRui Medical gets PFO occluder registration acceptance
August 18, 2025 at 09:00 AM UTC•By FilingReader AI
Beijing BaiRui Medical Technology's PFO occluder application was accepted by the National Medical Products Administration. The Class III device treats patent foramen ovale, a structural heart defect.
The company noted PFO occluder implantations increased from 21,000 in 2021 to 54,000 in 2024, indicating growing market demand.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:688198•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Beijing Balance Medical Technology publishes news
Free account required • Unsubscribe anytime